Revelation Biosciences, Inc. (REVB)
1.07
-0.02
(-2.28%)
USD |
NASDAQ |
Jun 01, 14:56
Revelation Biosciences Total Assets (Quarterly) : 15.04M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Agenus, Inc. | 186.46M |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
| Anika Therapeutics, Inc. | 179.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.055M |
| Shareholders Equity (Quarterly) | 12.99M |
| Debt to Equity Ratio | 0.0584 |
| Current Ratio | 10.02 |
| Net Debt Paydown Yield | -3.24% |